Birdwatch Note
2024-10-30 12:18:23 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
ターボ癌という医学用語はありません。 またワクチン接種でがんが増えるという科学的根拠はありません。 実際に、がんによる死亡者数の傾向は接種前後で変化していません。 接種による獲得免疫の促進は自然免疫系の抑制を意味するものでなく「がんに対する免疫には影響を与えない」し、接種ががん等の健康問題を引き起こすとの主張は裏付けとなる証拠がない憶測に基づくなどと既に検証・指摘されています。 https://www.cancer.gov/about-cancer/coronavirus/covid-19-vaccines-people-with-cancer https://www.cancer.org/cancer/managing-cancer/coronavirus-covid-19-and-cancer/covid-19-vaccines-in-people-with-cancer.html
Written by 600FD0363C54FF998A92BA8063786EDEE94D51BFDDDA7E4B6EB475D435244AD2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1851598786126385492
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1851599528669114677
- noteId - 1851599528669114677
- participantId -
- noteAuthorParticipantId - 600FD0363C54FF998A92BA8063786EDEE94D51BFDDDA7E4B6EB475D435244AD2 Participant Details
- createdAtMillis - 1730290703347
- tweetId - 1851598786126385492
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- ターボ癌という医学用語はありません。 またワクチン接種でがんが増えるという科学的根拠はありません。 実際に、がんによる死亡者数の傾向は接種前後で変化していません。 接種による獲得免疫の促進は自然免疫系の抑制を意味するものでなく「がんに対する免疫には影響を与えない」し、接種ががん等の健康問題を引き起こすとの主張は裏付けとなる証拠がない憶測に基づくなどと既に検証・指摘されています。 https://www.cancer.gov/about-cancer/coronavirus/covid-19-vaccines-people-with-cancer https://www.cancer.org/cancer/managing-cancer/coronavirus-covid-19-and-cancer/covid-19-vaccines-in-people-with-cancer.html
Note Ratings
rated at | rated by | |
2024-10-31 18:16:03 -0500 | Rating Details | |
2024-10-31 18:02:43 -0500 | Rating Details | |
2024-10-31 17:48:50 -0500 | Rating Details | |
2024-10-31 17:22:55 -0500 | Rating Details | |
2024-10-31 16:55:05 -0500 | Rating Details | |
2024-10-31 15:46:30 -0500 | Rating Details | |
2024-10-31 10:01:22 -0500 | Rating Details | |
2024-10-31 01:00:23 -0500 | Rating Details | |
2024-10-30 22:27:27 -0500 | Rating Details | |
2024-10-30 18:23:47 -0500 | Rating Details | |
2024-10-30 11:44:54 -0500 | Rating Details | |
2024-10-30 10:28:21 -0500 | Rating Details | |
2024-10-30 10:18:29 -0500 | Rating Details | |
2024-10-30 09:28:25 -0500 | Rating Details | |
2024-10-30 09:06:33 -0500 | Rating Details | |
2024-10-30 08:26:41 -0500 | Rating Details | |
2024-11-02 18:42:38 -0500 | Rating Details | |
2024-11-02 10:00:53 -0500 | Rating Details | |
2024-11-02 08:14:37 -0500 | Rating Details | |
2024-11-02 08:10:16 -0500 | Rating Details | |
2024-11-02 07:43:00 -0500 | Rating Details | |
2024-11-02 06:24:45 -0500 | Rating Details | |
2024-11-01 09:30:19 -0500 | Rating Details | |
2024-11-01 08:59:58 -0500 | Rating Details | |
2024-11-01 07:08:20 -0500 | Rating Details | |
2024-11-01 05:31:49 -0500 | Rating Details | |
2024-11-01 04:48:24 -0500 | Rating Details | |
2024-11-01 04:35:38 -0500 | Rating Details | |
2024-11-01 02:44:52 -0500 | Rating Details | |
2024-10-31 23:45:05 -0500 | Rating Details | |
2024-10-31 21:06:55 -0500 | Rating Details | |
2024-10-31 20:45:30 -0500 | Rating Details | |
2024-10-31 20:16:14 -0500 | Rating Details | |
2024-10-31 20:14:08 -0500 | Rating Details | |
2024-10-31 20:04:41 -0500 | Rating Details | |
2024-11-02 11:04:30 -0500 | Rating Details | |
2024-11-02 08:49:12 -0500 | Rating Details | |
2024-11-02 07:41:34 -0500 | Rating Details | |
2024-11-02 06:49:32 -0500 | Rating Details | |
2024-11-02 06:10:48 -0500 | Rating Details | |
2024-11-02 05:59:39 -0500 | Rating Details | |
2024-11-02 05:02:56 -0500 | Rating Details | |
2024-11-02 03:23:49 -0500 | Rating Details | |
2024-11-01 22:32:19 -0500 | Rating Details | |
2024-11-01 18:52:24 -0500 | Rating Details | |
2024-11-01 18:39:19 -0500 | Rating Details | |
2024-11-01 18:12:29 -0500 | Rating Details | |
2024-11-01 17:55:31 -0500 | Rating Details | |
2024-11-01 17:18:58 -0500 | Rating Details | |
2024-11-01 11:26:08 -0500 | Rating Details | |
2024-11-01 11:07:41 -0500 | Rating Details | |
2024-11-01 10:58:58 -0500 | Rating Details | |
2024-11-01 09:54:08 -0500 | Rating Details | |
2024-11-01 09:18:20 -0500 | Rating Details | |
2024-11-01 07:18:11 -0500 | Rating Details | |
2024-11-01 07:02:45 -0500 | Rating Details | |
2024-11-01 07:00:07 -0500 | Rating Details | |
2024-11-01 06:42:25 -0500 | Rating Details | |
2024-11-01 06:04:48 -0500 | Rating Details | |
2024-11-01 05:03:39 -0500 | Rating Details | |
2024-11-01 03:55:28 -0500 | Rating Details | |
2024-11-01 03:23:52 -0500 | Rating Details | |
2024-11-01 00:57:41 -0500 | Rating Details | |
2024-10-31 23:28:29 -0500 | Rating Details | |
2024-10-31 23:19:01 -0500 | Rating Details | |
2024-10-31 22:36:47 -0500 | Rating Details | |
2024-10-31 21:12:43 -0500 | Rating Details | |
2024-10-31 18:41:52 -0500 | Rating Details | |
2024-10-31 18:35:27 -0500 | Rating Details | |
2024-10-31 18:27:46 -0500 | Rating Details | |
2024-10-31 16:50:24 -0500 | Rating Details | |
2024-10-31 16:20:10 -0500 | Rating Details | |
2024-10-31 10:06:59 -0500 | Rating Details | |
2024-10-30 18:22:27 -0500 | Rating Details | |
2024-10-30 15:28:36 -0500 | Rating Details | |
2024-10-30 11:32:48 -0500 | Rating Details | |
2024-10-30 11:00:30 -0500 | Rating Details | |
2024-10-30 09:23:12 -0500 | Rating Details | |
2024-10-30 08:55:59 -0500 | Rating Details |